1. NAV-001, a high-efficacy antibody-drug conjugate targeting mesothelin with improved delivery of a potent payload by counteracting MUC16/CA125 inhibitory effects
   Nicholas C. Nicolaides et al, 2023, PLOS ONE CrossRef
2. NAV‐003, a bispecific antibody targeting a unique mesothelin epitope and CD3ε with improved cytotoxicity against humoral immunosuppressed tumors
   Luigi Grasso et al, 2023, European Journal of Immunology CrossRef